Background: Long non-coding RNAs (lncRNAs) have been shown to play central roles in diverse oncogenic contexts. Database-based bioinformatics analyses indicated that pancreatic cancer (PC) samples exhibit the upregulation of the lncRNA EGOT. The present study was therefore designed to explore the role of this lncRNA in PC, focusing on its ability to regulate the EGOT/miR-214/PLS3 axis.Methods: A qPCR approach was used to quantify EGOT, miR-214, and PLS3 mRNA levels in PC cells, while PLS3 protein levels were examined via Western blotting. Tumor cell invasivity and proliferation were measured through CCK-8, EdU, and wound healing assays. The impact of EGOR knockdown on in vivo PC tumor growth was additionally assessed. Results: EGOT upregulation was observed in PC cells, and the knockdown of this lncRNA significantly impaired their migration, proliferation, and invasion. Direct binding interactions between miR-214 and both EGOT and PSL3 were detected, and miR-214 inhibition was sufficient to partially reverse the impact of EGOT knockdown on PLS3 expression and PC cell proliferative and migratory activity. Knocking down EGOT also suppressed the in vivo growth of PC tumors, and relationships between EGOT, miR-214, and PLS3 were confirmed in this animal model system. Conclusion:We confirmed that EGOT serves as an important regulator of PC development, suggesting that it may be a valuable diagnostic biomarker and/or therapeutic target in this oncogenic context.